http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2943150-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-14276
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-1723
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H20-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-142
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-172
filingDate 2014-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1da86fb46d1e66a211c0893c3cd4456
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_baa4a50195de55bf4f703507f136e6c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b3df777234734307d994ab1a369aaa2
publicationDate 2015-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2943150-A1
titleOfInvention Daily periodic target-zone modulation in the model predictive control problem for artificial pancreas for type i diabetes applications
abstract A controller for an artificial pancreas for automated insulin delivery to patients with type 1 diabetes mellitus (T1DM) that enforces safe insulin delivery throughout both day and night, wherein the controller employs zone model predictive control, whereby real-time optimization, based on a model of a human's insulin response, is utilized to regulate blood glucose levels to a safe zone, and time-dependent zones that smoothly modulate the controller correction based on the time of day, wherein the controller strategically strives to maintain an 80-140 mg/dL glucose zone during the day, a 110-220 mg/dL zone at night, and a smooth transition of 2 hour duration in between.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111710009-A
priorityDate 2013-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396684
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16186314

Total number of triples: 25.